| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |